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Abstract
Background: Rabies is a zoonosis transmitted via the bites of various mammals, primarily dogs and bats. Known
since antiquity, this disease may have the deadliest human fatality rates and is responsible for approximately 65,000
deaths worldwide per year.
Case presentation: We report the case details of a 13-year-old boy from India belonging to a South Asian ethnicity,
who presented with altered sensorium one month following a dog bite. He did not receive the active rabies
immunization and was managed with supportive therapy. The patient had extensive T2W (T2 weighted)/fluid
attenuation and inversion recovery (FLAIR) hyper intensities involving the deep gray matter of the cerebral
hemispheres, hippocampus, brainstem, and cerebellum. The diagnosis was confirmed by the demonstration of
the rabies antigen from a nuchal skin biopsy and a corneal smear. The patient had a slow but significant
recovery over four months and was discharged from the hospital in stable condition with severe neurological
sequelae.
Conclusion: We report a unique case of survival after infection with a universally fatal disease.
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Background
Rabies is a zoonosis that is transmitted to humans from
the bite of a rabid animal. The rabies virus is usually
transmitted via dog, fox, and/or bat bites. The rabies
virus is Genus Lyssa, a member of the Rhabdoviridae
virus family. Rabies manifests most often as encephalitis
in two clinical forms known as the furious or dumb
types [1]. The former (furious) is observed in 80 % of
patients, and the dumb (paralytic) variety is observed in
the remaining 20 % of patients. Rabies encephalitis has
the highest case fatality rates of any infectious disease
and is responsible for approximately 65,000 deaths
per year worldwide. India is a major contributor to
the mortality rate, accounting for more than half of
all deaths [2].
The medical community had renewed its interest in
rabies with the publication of a case of a rabies survivor
who was treated with a novel protocol known as the
Milwaukee protocol (MP) [3]. Subsequent investigators
who used this protocol did not find any reduction in
mortality rates, and the disease still remains uncon-
quered by modern medicine [4]. There are only 13
reported cases of rabies survivors worldwide to date; the
last case was reported in India in April, 2014 [5]. We
report another patient with this deadly disease who
survived with the help of intensive critical care support.
Case presentation
A 13-year-old boy from India belonging to South Asian
ethnicity had sustained an unprovoked bite on his right
hand from a street dog on Aug. 26, 2014. He was taken
to a local hospital where the wound was cleaned, and
was given the first dose of intramuscular (im) Rabipur as
part of the post-exposure prophylactic (PEP) treatment.
He was not given rabies immunoglobulin and received
two more doses of im Rabipur on days 3 and 7 after the
bite. The patient complained of headache and fever from
the 10th day and was treated symptomatically by the
local physician. Over the next two days he started vomit-
ing and became drowsy. He was brought to our hospital
35 days after the dog bite with an altered state of
consciousness. His initial clinical examination revealed
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normal vital parameters with no dysautonomic features.
Neurological examination showed a Glasgow Coma
Scale (GCS) of 11/15 (E2 M5 V4) and intact brain
stem reflexes along with signs of meningeal irritation.
He had no focal neurological deficits, and a fundal exam-
ination was normal.
He was initially treated with broad spectrum antibi-
otics as well as antimalarial agents in response to febrile
encephalopathy in an endemic region and was investi-
gated for possible etiologies. His hematological and bio-
chemical parameters were normal. Screening for malaria
and toxic substances, including lead and benzodiaze-
pines, showed negative results. Cerebrospinal fluid (CSF)
analysis showed lymphocytic pleocytosis (WBC-20), ele-
vated proteins (76 mg/dl), normal glucose (60 mg/dl,
blood glucose of 112 mg/dl), and negative staining
(Gram stain, Acid fast bacilli, India ink preparation) of
the CSF culture. The initial magnetic resonance im-
aging (MRI) showed bilateral thalamus and brainstem
hyperintensities in the T2W and FLAIR images without
diffusion restriction or hemorrhages on the gradient;
these findings were suggestive of encephalitis (Fig. 1a).
The possible diagnoses after neuroimaging were Japanese
B-, West Nile-, or rabies-associated encephalitis. The CSF
screen was negative for Herpes, Japanese B, and West
Nile viruses by RT-PCR. In view of the possibility of ra-
bies encephalitis, he was evaluated using paired serum
and CSF samples for antibody titers. The paired sera
showed the antibody titers in excess of 1:60,000 dilu-
tion after 45 days of vaccine treatment confirming the
diagnosis of rabies infection. Subsequent to these re-
sults, other samples were collected from the nape of
the neck and the cornea. The presence of the rabies
antigen in the nerve twigs confirmed the diagnosis of
rabies encephalitis. The confirmatory tests were con-
ducted at the Department of Virology, Armed Forces
Medical College (AFMC), Pune and the National Insti-
tute for Mental Health and Neurological Sciences
(NIMHANS), Bengaluru.
He was managed in the intensive care unit (ICU) with
ventilator support, barrier nursing, and strict universal
precautions. The ICU course was complicated by venti-
lator associated pneumonia, autonomic storms, and re-
current seizures. The sympathetic storm management
included the use of intravenous labetalol for tachycardia
and hypertension. His management included broad
spectrum antibiotics for Pseudomonas pneumonia,
prophylaxis for deep vein thrombosis, a tracheostomy,
antiepileptic drugs, and aggressive physiotherapy. For
approximately three weeks, he remained comatose with
a motor score of 3 and a GCS score of 5 with pro-
nounced bulbar palsy. Nutritive requirements were met
by the nasogastric feeds. He was weaned off of the venti-
lator after eight weeks of illness.
Over the next two months he developed spontaneous
eye opening and was able to follow verbal commands.
Motor functions partially improved with spontaneous
movements of the limbs and truncal muscles. He contin-
ued with aggressive physiotherapy, and after five months
of hospitalization, he was discharged in stable condition
with neurological sequelae. MRI scans were conducted
at serial intervals and showed the reduction of hyperin-
tensities along with marked cortical atrophy (Fig. 1b).
During the last review (two months after discharge), the
Fig. 1 MRI images (FLAIR) performed one month after the patient was bitten; hyperintensities in the basal ganglia (white arrows), thalamus, pons,
and medulla (a) and brain atrophy (b) are shown
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patient was able to make meaningful eye contact and
follow single step commands.
Discussion
Rabies encephalitis is almost always a fatal disease, and
therapy has mostly been palliative. Prior to 2004, there
were only five documented human survivors, all of
whom had received the PEP, albeit incomplete or late
[5]. In 2004, the first survivor without PEP was reported
after this individual had undergone the MP. However,
the use of the MP did not increase survival in subse-
quent cases [6]. Our patient was managed with aggres-
sive supportive care without the MP or steroids. Our
patient survived the acute phase of rabies encephalitis
and was discharged after five months of intensive nurs-
ing care in the hospital.
The reasons for patient survival after rabies infection
are always conjectural depending on the number of sur-
vivors of this disease [7]. The presence of high antibody
titers in the CSF could be a strong predictor for limited
neurological damage, which may help lead to survival.
Unfortunately, similar data from other survivors could
not be assessed; therefore, we lacked any comparative
data. Another possible reason could be the intensive
nursing care and proper management of the autonomic
storms. Genetic variability in the host immune response
to the rabies virus could also be another contributory
factor to survival.
The ongoing viral effects with associated devastating
brain injury were observed in serial MRI scans [8]. How-
ever, intensive supportive care allows the immune re-
sponse to clear the virus while retaining the potential for
reversing the neurologic consequences. This resulted in
a slow recovery despite the massive initial neurological
damage. Out of the seven reported rabies survivors until
2008, only the index case that used the MP did not
receive PEP. Rabies virus was detected in only one case
in all of the others that were diagnosed using only the
rabies antibody [9]. Our case was diagnosed using both
the rabies antibody and highly specific rabies antigen
detection tests.
Conclusions
In conclusion, we report the case details of a young boy
who survived rabies, a disease with few survivors. Our
report along with other published reports, should give
more impetus to researchers to unravel the mechanisms
to conquer the rabies infection.
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